CD19-targeting CAR T-cell immunotherapy yields high responses in treatment-resistant CLL

In a small, early phase trial, a high percentage of patients who had exhausted most traditional treatments for chronic lymphocytic leukemia saw their tumors shrink or even disappear after an infusion of a highly targeted, experimental CAR T-cell immunotherapy.

from Top Health News – ScienceDaily http://bit.ly/2gbO8dB
from Tumblr http://bit.ly/2gHqM0b